)
BellRing Brands (BRBR) investor relations material
BellRing Brands Q4 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q4 net sales rose 6.8% to $692.0M; Adjusted EBITDA was $66.4M, including a $16M pre-tax inventory-related headwind.
FY26 net sales increased 3.5% to $2,398.4M; Adjusted EBITDA fell to $288.8M, with $37M of inventory-related headwinds.
FY27 is framed as a year of foundational progress, with margin expansion expected despite near-term sales pressure from pricing elasticity and retailer inventory adjustments.
Long-term financial targets were withdrawn during a strategic review; updated strategy and outlook are expected with the Q2 FY27 earnings call.
Financial highlights
Q4 gross profit was $152.3M, or 22.0% of sales, versus $187.4M and 28.9%; adjusted gross profit was $138.9M, or 20.1%, versus $192.4M and 29.7%.
Q4 diluted EPS was $0.31 versus $0.48; adjusted diluted EPS was $0.22 versus $0.51, and adjusted net earnings were $26.0M versus $63.4M.
FY26 gross profit was $638.1M, or 26.6% of sales; adjusted gross profit was $593.6M, or 24.7%, versus $785.6M and 33.9% a year earlier.
FY26 diluted EPS was $1.25 versus $1.68; adjusted diluted EPS was $1.04 versus $2.17, and adjusted net earnings were $122.0M versus $279.1M.
Q4 SG&A was $80.2M, down $0.7M YoY; FY26 SG&A was $343.4M, down $52.6M, including $5.9M of reorganization charges.
Outlook and guidance
FY27 net sales guidance is $2.32B–$2.42B and Adjusted EBITDA guidance is $310M–$350M, or approximately 14% of sales at the midpoint; capital expenditures are expected to be $3M.
Premier shakes are expected to range from 2% growth to 2% decline; powders and Dymatize contribute an approximately 100 bps headwind to sales growth.
Adjusted gross margin is expected to expand nearly 400 bps, supported by low-double-digit shake pricing, approximately $25M in cost savings, and favorable comparisons to FY26 inventory items.
FY27 Premier RTD consumption is expected to grow mid-single digits, while shipments trail consumption and create a mid-single-digit headwind to net sales growth.
Q1 FY27 net sales are expected to grow low single digits, with Premier RTD consumption up low to mid-teens and Adjusted EBITDA margin just under 17% at the midpoint.
- Net sales rose 4% but margins fell on inventory charges; price hikes and cost cuts planned for 2027.BRBR
Q3 2026 - Q2 sales rose 2% but margins and earnings fell sharply amid inflation and inventory charges.BRBR
Q2 2026 - Net sales up 1% to $537.3M, margins fell, 2026 outlook narrowed, CEO transition and settlements announced.BRBR
Q1 2026 - All proposals passed with strong support and no shareholder questions were raised.BRBR
AGM 2026 - Strong 2025 sales and brand momentum, with 2026 guidance showing growth and margin pressure.BRBR
Q4 2025 - Net sales and earnings surged, guidance raised, and Premier Protein drove record growth.BRBR
Q3 2024 - Premier Protein drove strong sales and EBITDA growth, with double-digit 2025 outlook despite margin pressures.BRBR
Q4 2024 - Q2 net sales up 19% with Premier Protein driving record growth; FY2025 outlook reaffirmed.BRBR
Q2 2025 - Q1 net sales up 24% and net earnings up 75%, with FY25 outlook raised on Premier Protein strength.BRBR
Q1 2025
)
)
)
)
)
)
)
)